Metraipolis › archive › dc_9d389f6e92cd

Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysis — Europe PMC PMID:42022227

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42022227
DOI
10.1002/bco2.70194
License (as archived)
solo-consultazione
Archived
2026-10-18T12:01:52.416Z
SHA-256 of the archived text
cc07b000e713326303d43bd2732f38c7285a63f49e15a69a116c423970903465
Stable URL of this page
https://metraipolis.com/documento/dc_9d389f6e92cd

How to cite

Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysis — Europe PMC PMID:42022227 — Europe PMC (en), https://europepmc.org/article/MED/42022227 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9d389f6e92cd (Metraipolis archive dc_9d389f6e92cd, sha256 cc07b000e713326303d43bd2732f38c7285a63f49e15a69a116c423970903465)
BibTeX
@misc{dc9d389f6e92cd,
  title = {Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysis — Europe PMC PMID:42022227},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42022227},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9d389f6e92cd; sha256 cc07b000e713326303d43bd2732f38c7285a63f49e15a69a116c423970903465},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42022227. Agents can read the archived copy with the MCP tool read_document.